Growth and Differentiation Factor 2022 Size, Growth Analysis Report, Forecast to 2028
The global growth and
differentiation factor market is anticipated to grow at a significant CAGR
during the forecast period (2022-2028). Growth differentiation factors (GDFs)
are a subfamily of the transforming growth factor-beta superfamily of proteins
that have a role in tissue development and cancer. The market is mainly driven
due to the increasing prevalence of ovarian and breast cancer coupled with
rising awareness regarding breast cancer.
To Request a Sample of our Report on Growth and
Differentiation Factor: https://www.omrglobal.com/request-sample/growth-and-differentiation-factor-market
In the UK, female breast cancer is the most common
type of breast cancer and accounts for 552,000 of new cancer cases every year,
as per the Cancer Research UK. Female breast cancer accounted for 11,399
fatalities in the UK, between 2015-2017. Moreover, the expenditure on breast
cancer by the government and private industries for therapeutics and medicines
supports the growth of the market. The global expenditure such as the total
funding of government organizations and private organizations on breast cancer
is high compared to other cancers. In October 2019, the Breast Cancer Research
Foundation (BCRF) announced its $66 million commitment to fund breast cancer
research for 2019-2020. The grants will support the work of nearly 275
scientists at leading academic and medical institutions across the globe. The
world’s breast cancer organization Susan G. Komen, announced the research
funding of $30.7 million for 98 research grants in 2017. The organization also
focuses on new treatment and understanding of the most mortal forms and stages
of breast cancer. Susan G. Komen provides funds for breast cancer research in
27 states and 7 countries including the US, Middle East and Latin America. It
also involves in research for new screening technologies, treatments for metastatic
types of breast cancer and differences in breast cancer consequences. The
research funding opportunity is expected to offer an opportunity for the
development of novel GDF therapies. This, in turn, will likely accelerate the
growth of the global growth and differentiation factor market.
Market Coverage
·
The market number available for – 2020-2027
·
Base year- 2020
·
Forecast period- 2022-2028
Segment Covered-
·
By Product Type
Regions Covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
Competitive Landscape- Pfizer Inc, Merck & Co, Inc., and Novartis
International AG, among others.
(Get 15% Discount on Buying this Report)
A
full Report of Growth and Differentiation Factor is Available @ https://www.omrglobal.com/industry-reports/growth-and-differentiation-factor-market
Global Growth and Differentiation Factor Market Report by Segment
By Product Type
·
GDF-5
·
GDF-6
·
GDF-8
·
GDF-9
·
GDF-11
·
GDF-15
Global Growth and Differentiation Factor Market Report by
Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert research
analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no:
+91 7803040404
Comments
Post a Comment